Pangenomic Health Inc. Share Price
Equities
NARA
CA69842E3041
Advanced Medical Equipment & Technology
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.06 CAD | 0.00% | -25.00% | -70.00% |
27/05 | Pangenomic Health Inc. announced that it has received CAD 1.075116 million in funding | CI |
17/05 | Pangenomic Health Inc. announced that it expects to receive CAD 1 million in funding | CI |
Sales 2021 | - | Sales 2022 | - | Capitalization | 19.99M 27.42M 1.67B |
---|---|---|---|---|---|
Net income 2021 | -2M -2.74M -167M | Net income 2022 | -12M -16.46M -1B | EV / Sales 2021 * | - |
Net cash position 2021 | 1.35M 1.85M 112M | Net Debt 2022 | 13.24K 18.17K 1.1M | EV / Sales 2022 | - |
P/E ratio 2021 * |
-
| P/E ratio 2022 |
-1.23
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 97.2% |
1 week | -25.00% | ||
Current month | -25.00% | ||
1 month | -33.33% | ||
3 months | -60.00% | ||
6 months | -80.00% | ||
Current year | -70.00% |
Managers | Title | Age | Since |
---|---|---|---|
Maryam Marissen
CEO | Chief Executive Officer | - | 06/22/06 |
Tammy Gillis
DFI | Director of Finance/CFO | 50 | 01/21/01 |
Derek Ho
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 57 | 16/02 | |
Robert Nygren
FOU | Founder | 60 | 11/15/11 |
Maryam Marissen
CEO | Chief Executive Officer | - | 06/22/06 |
Date | Price | Change | Volume |
---|---|---|---|
17/24/17 | 0.06 | -29.41% | 1,412 |
14/24/14 | 0.085 | -15.00% | 5,400 |
13/24/13 | 0.1 | +5.26% | 33,000 |
Delayed Quote Canadian Securities Exchange, June 18, 2024 at 01:14 am IST
More quotes1st Jan change | Capi. | |
---|---|---|
-70.00% | 1.4M | |
-6.59% | 29.06B | |
+39.31% | 9.19B | |
+36.91% | 4.58B | |
-34.57% | 2.49B | |
-9.44% | 1.6B | |
-24.82% | 1.28B | |
-39.44% | 1.04B | |
+4.74% | 940M | |
-41.98% | 809M |
- Stock Market
- Equities
- NARA Stock